Advanced or Metastatic Colorectal Cancer (mCRC)
2 clinical trials · Condition
◉ Watch Advanced or Metastatic Colorectal Cancer (mCRC)
| Record | Firm | Date |
|---|---|---|
| First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors (NCT03616574) | Holy Stone Healthcare Co., Ltd | 2019-04-09 |
| Individual Patient Expanded Access to CA102N (NCT05274204) | Holy Stone Healthcare Co., Ltd |
Track Advanced or Metastatic Colorectal Cancer (mCRC) automatically
Every clearance here is in the API, with alerts when new ones post.